Annual report [Section 13 and 15(d), not S-K Item 405]

Segment Information (Tables)

v3.25.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Information  
Schedule of significant segment expenses

For the years ended December 31, 2024 and 2023, the significant expense categories regularly provided to the CODM consisted of the following (in thousands):

    

For the year ended December 31,

2024

2023

Revenue - related party

$

41

$

103

Operating expenses:

 

  

 

  

Employee Expenses

 

8,624

 

7,285

Stock-based Compensation

 

15,252

 

2,897

Fortress Founder's Agreement and MSA Expenses

 

9,133

 

4,871

Manufacturing and Development Expenses

 

10,755

 

19,013

Clinical Expenses

 

3,901

 

6,981

Regulatory Expenses

 

334

 

3,615

License Fees

 

152

 

2,300

Legal & Accounting Expense

 

4,123

 

1,814

R&D Other Expense (1)

 

1,629

 

1,439

G&A Other Expense (2)

 

2,312

 

2,036

Total Operating Expenses

 

56,215

 

52,251

Other Segment Items (3)

(66)

301

Net Loss

$

(56,240)

$

(51,847)

(1) R&D Other Expense includes travel, consulting, and outside service expenses.

(2) G&A Other Expense includes travel, consulting, marketing, business development, investor relations and outside services expenses.

(3) Other Segment Items include interest income, foreign currency exchange loss, and gain (loss) on common stock warrant liabilities.